Your fact-checks will appear here
The Trump administration’s early 2025 budget actions and policy changes led to large, specific reductions and program shifts at NIH and the National Cancer Institute (NCI): reporting and committee ana...
Available reporting shows multiple actions by the Trump administration and Congressional maneuvers in 2024–2025 that critics say reduced federal support for pediatric cancer research — including propo...
No explicit, formal endorsements or dedicated recommendations for repurposed antiparasitic drugs appear in the recent guideline summaries and updates from the National Comprehensive Cancer Network (NC...
The only published outcome from the ivermectin + immunotherapy TNBC effort tied to ClinicalTrials.gov identifier NCT05318469 through the end of 2025 is an ASCO 2025 meeting abstract reporting safety a...
Federal budget actions in 2025 have led to large, rapid reductions in NIH/NCI funding and related programs that press experts warn will hit specific cancer research activities hard: Democratic staff a...
Lawmakers from both parties publicly objected to NIH and cancer-research funding cuts, but available reporting emphasizes prominent Democratic-led pushback and congressional scrutiny rather than an eq...